Saturday, August 18, 2018
 
 
Company News: Page (1) of 1 - 08/08/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Oralogica offers consumers vital information on potentially harmful mouthwash ingredients as identified by U.S. Government’s National Institute of Health’s PUBCHEM

(August 08, 2018)

The new Kickstarter campaign features ORALOGICA’s technological breakthrough in organic and natural oral care products.  This is a significant breakthrough in delivering new and natural benefits to the consumer marketplace.

Are you aware that almost every bottle of mouthwash carries a warning label about the poisons contained within your mouthwash? Part of this campaign is to help consumers make educated choices by providing easy access to information on many competitors ingredients.  Oralogica’s website https://www.oralogica.com/compare/mouthwash/ features the ingredients of most current mouthwash on the market and identifies the potentially harmful chemicals or ingredients that are flagged on the U.S. Governments National Institute of Health’s PUBCHEM web site. (pubchem.ncbi.nlm.nih.gov)

This was a key objective in developing Oralogica’s RINSE product line, which contains organic essential oils and fortified with organic vitamins and organic minerals.  The company has patent-pending breakthrough technology that allows its products to eliminate the need for these harsh chemicals that are currently used in other mouthwash brands in the market.



Oralogica’s products are 100% natural and the benefits include whitening the teeth, fighting biofilm, fighting bad breath, protection against demineralization and cavities, and nourishing the whole mouth including roots, nerves and dentin.

The company is also committed to improving the environment and product efficacy with glass packaging that can be re-used as a water bottle.Made in the USA using domestic and imported ingredients.

Oralogica is the innovative personal care product company, regarded as “the first organic personal care product company created from a passion to change the world.” The company offers a wide range of organic oral care products and recently launched a campaign on Kickstarter with the aim of raising funds for its new line of products.

More information about the campaign and the products can be found on the website. Oralogica is also available across different social media platforms including Facebook, Twitter, and Instagram.

About Oralogica

ORALOGICA is the first organic personal care product company created from a passion to change the world by providing you and your family with superior organic oral care products that are healthy and effective. Founded by David Dolezal, Oralogica offers a wide range of products designed to help eliminate the need for all harmful ingredients currently in the market. The company is headquartered in Scottsdale, Arizona.

For more information, visit: www.oralogica.com

Media Contact
Company Name: ORALOGICA, LLC.
Contact Person: Mindi Osborn
Email: [email protected]
Phone: +1 602 885 6306
Country: United States
Website: https://www.oralogica.com



Source: www.abnewswire.com


Page: 1


Related Keywords:Family & Parenting,Health & Medicine,Hospitality,Shopping & Deal,U.S,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines